Insider Transactions in Q1 2021 at Inspire Medical Systems, Inc. (INSP)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 12
2021
|
Richard Buchholz Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+4.37%
|
$312,500
$25.08 P/Share
|
Feb 26
2021
|
Steven Jandrich VP, Human Resources |
SELL
Open market or private sale
|
Direct |
10,000
-86.92%
|
$2,350,000
$235.0 P/Share
|
Feb 26
2021
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.04%
|
$260,000
$26.27 P/Share
|
Feb 25
2021
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-5.75%
|
$4,520,000
$226.11 P/Share
|
Jan 29
2021
|
Bryan K Phillips Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,275
+50.0%
|
-
|
Jan 21
2021
|
Richard Buchholz Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
480
+10.71%
|
-
|
Jan 21
2021
|
Richard Buchholz Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
480
-1.05%
|
-
|
Jan 08
2021
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
64
+29.63%
|
$12,416
$194.1 P/Share
|
Jan 08
2021
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+3.94%
|
$13,580
$194.1 P/Share
|
Jan 08
2021
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
106
+3.12%
|
$20,564
$194.1 P/Share
|
Jan 08
2021
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.37%
|
$13,580
$194.1 P/Share
|
Jan 08
2021
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+50.0%
|
$9,118
$194.1 P/Share
|
Jan 04
2021
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
30,187
-40.91%
|
$5,524,221
$183.9 P/Share
|
Jan 04
2021
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,187
+41.46%
|
$30,187
$1.61 P/Share
|